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Introduction
Pancreatic fluid collections (PFCs) can develop as a consequence of pancreatic duct leak/disruption or pancreatic inflammation [1 – 3]. A pancreatic pseudocyst is a type of PFC enclosed in a non-epithelialized wall. While pseudocysts develop
in up to 20 % of cases of acute pancreatitis and 40 % of patients
with chronic pancreatitis, most of them resolve spontaneously
[4]. Treatment is warranted in the setting of symptoms (i. e. abdominal pain, early satiety, weight loss, luminal and/or biliary
obstruction) and/or cyst-associated adverse events (i. e. infection, bleeding) [5].
Endoscopic transmural (TM) drainage has become first-line
therapy for symptomatic pancreatic pseudocysts given its similar efficacy, shorter recovery times, fewer adverse events (AEs)
and improved cost-effectiveness when compared to surgical
cystogastrostomy [6]. This technique involves the creation of a
communication between the pseudocyst and the gastroduodenal lumen (cystogastrostomy or cystoduodenostomy), allowing
the internal drainage and collapse of the pseudocyst [7].
Several factors have been associated with the technical and
clinical success of endoscopic drainage. Presence of solid debris
within the cystic cavity has been historically regarded as a negative factor on endoscopic drainage, in part due to the worse
clinical outcomes in patients with walled-off necrosis (WON)
[8]. The revised Atlanta classification distinguishes different
types of PFCs based on morphologic features seen on contrastenhanced computed tomography (CECT) [1]. WON is defined as
a heterogeneous collection with varying amounts of non-liquid
density that has developed from acute necrotizing pancreatitis
whereas a pseudocyst is defined as a well-encapsulated homogenous fluid collection with minimal or no solid debris arising
from interstitial edematous pancreatitis. In spite of this categorical distinction, it is not uncommon in clinical practice to encounter some degree of solid debris within a pseudocyst at the
time of EUS-guided drainage. However, as opposed to WON,
data on clinical outcomes of TM drainage of pseudocysts containing variable amount of solid debris (PSD) are very limited.
The primary aim of this multicenter, retrospective study was to
compare symptomatic and radiologic resolution rates at followup in patients undergoing EUS-guided drainage of debris-free
pseudocysts (PDF) versus PSD. A secondary aim was to assess
the need for endoscopic re-intervention and adverse events between the two groups.

Patients and methods
This multicenter retrospective study included all consecutive
patients aged ≥ 18 years who underwent attempted EUS-guided pseudocyst drainage at 15 academic tertiary referral centers
in the United States between January 2008 and September
2014. Patients were identified through prospectively maintained endoscopic databases and chart review. All data were
extracted and compiled into a central database. Informed procedural consents were obtained from all patients. This study
was approved by the institutional review board for human research at each of the participating institutions. All endoscopic
procedures were performed according to the ASGE practice

guideline recommendations on antibiotic prophylaxis and management of antithrombotic agents and coagulopathy [9, 10].
All patients with clinical and/or radiographic evidence of necrotizing pancreatitis and features of WON on index imaging
(based on the revised Atlanta classification) were excluded. All
patients who had any other form of intervention (i. e. percutaneous, surgical and/or endoscopic transpapillary drainage)
prior to EUS-guided drainage were also excluded.
Data collection was separated into 3 categories: baseline,
procedural, and post-procedural data. Baseline data of interest
included patient demographics, etiology of pancreatitis, presence of chronic pancreatitis, pseudocyst characteristics, and
findings on index imaging prior to drainage. Procedure-related
data included technical aspects for TM drainage. Relevant data
included presence or absence of solid debris within the pseudocyst, method of cystoenterostomy tract creation, route of
drainage, type and number of transmural stent(s) used. All procedure-related AEs were reviewed. Post-procedure data included duration of follow-up, need for additional intervention(s),
and treatment outcomes.

Definitions
PFCs were classified as per the revised Atlanta classification as
acute peripancreatic fluid collection (APFC), pseudocysts,
acute necrotic collection (ANC) or walled-off necrosis (WON)
[9]. AEs were assessed based on previously established criteria
by the American Society of Gastrointestinal Endoscopy (ASGE)
[11]. Patients were divided into 2 groups: debris-free pseudocyst (PDF) versus pseudocyst with solid debris (PSD); this definition was based on the pseudocyst characteristics found on
EUS examination at time of TM drainage. PDF was defined as
absence of any debris within a pseudocyst, whereas PSD was
defined as a pseudocyst containing variable amounts of solid
material (▶ Fig. 1). TM technical success was defined as successful placement of a minimum of one transmural stent during
pseudocyst drainage. Symptom resolution was defined as the
complete absence of any symptoms, including pain, gastric
outlet obstruction, biliary obstruction, and/or infection. Radiologic resolution was defined as the complete resolution of
the pseudocyst on repeat imaging at the time of follow-up.

Main outcome measures
The primary aim of the study was to compare symptomatic and
radiologic resolution of patients with PDF vs. PSD who underwent EUS-guided TM drainage. A secondary aim was to compare rates of endoscopic re-intervention and adverse events
between the two groups.

Follow-up
Clinical and radiologic follow-up was performed at the discretion of the endoscopist and care team at each participating institution. Treatment outcome measures were evaluated at both
short-term and long-term follow-up. In clinical practice, most
TM stents are usually kept in place for a period of 3 weeks to 5
weeks, at which time repeat evaluation (i. e. clinic visit, imaging) is performed in order to assess interval changes and help
dictate timing of stent removal. We defined short-term follow-
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the pseudocysts was similar in both groups: PDF (9.0 cm; IQR:
7.4 – 12.2 cm) and PSD (9.0 cm; IQR: 7.5 – 13.3 cm) (P = 0.92).
Overall, abdominal pain was the most common indication for
pseudocyst drainage in both groups (90 % in PDF vs. 92.3 % in
PSD; P = 0.77). Other indications included gastric outlet obstruction, biliary obstruction, and/or infection (▶ Table 1).

Technical parameters and outcomes
EUS-guided transmural drainage

▶ Fig. 1 a Endosonographic and endoscopic view of EUS-guided
transmural drainage of a debris-free pseudocyst. b Endosonographic and endoscopic view of EUS-guided transmural drainage of
a pseudocyst containing solid debris.

up as an interval ≥ 2 weeks following transmural stent placement but prior to stent removal in order to assess treatment efficacy at the time of patient reevaluation. Long-term follow-up
was defined as a period ≥ 2 weeks following transmural stent removal. The main objective of using this definition was to evaluate clinical outcomes once the stent had been removed and not
prior to this event.

Statistical analysis
Descriptive statistics were calculated for all demographic, imaging, and clinical variables and were reported as mean ± standard deviation (SD), median with interquartile ranges (IQR), and/
or as a proportion. Univariate analysis was performed by using
the chi-square test and the Fisher’s exact test for categorical
variables and Mann-Whitney test for continuous variables
when indicated. All statistical analysis was performed with the
SPSS software v22 (IBM, SPSS Statistics, Armonk, NY). A P value
less than 0.05 was considered statistically significant.

Results
Patient characteristics and pancreatic pseudocysts
Two hundred and fifteen patients underwent EUS-guided TM
drainage during the study period. A total of 142 patients were
diagnosed with pseudocysts based on the revised Atlanta classification [9]. Of these patients, there were 90 patients with
PDF and 52 with PSD based on EUS imaging characteristics at
the time of TM drainage.
Baseline characteristics of patients with pseudocysts who
underwent TM drainage are summarized in ▶ Table 1. There
was no significant differences in patient age, sex, etiology of
acute pancreatitis, presence of chronic pancreatitis or pseudocyst location in patients with PDF vs. PSD. The median size of

E132

The procedural technique of EUS-guided drainage for patients
with PDF vs. PSD is summarized in ▶ Table 2. In both groups, a
19-gauge EUS needle was used for access and fistula creation
via a transgastric or transduodenal approach in most cases.
There was no significant difference in the type of transmural
stent(s) used for pseudocyst drainage between the two groups.
The most common TM drainage intervention was placement of
a median of 2 10 Fr double-pigtail plastic stents (53.3 % in PDF
vs. 57.7 % in PSD; P = 0.73) or 2 7 Fr double-pigtail plastic stents
(38.9 % in PDF vs. 30.8 % in PSD; p = 0.37). In all cases where a
metal stent was placed for TM drainage (▶ Table 2), a 7 Fr or
10 Fr plastic double pigtail stent was placed through the lumen
for anchorage and to assist with drainage. Overall, stent(s) remained in place for a median of 97 and 95 days in the PDF and
PSD groups, respectively (P = 0.25).

Technical success and need for endoscopic re-intervention
Technical success rate for TM drainage was 96.7 % (87/90) in
PDF and 98.1 % (51/52) in PSD (P = 0.63). Reasons for failure in
the 3 patients from the PDF group included inability to dilate
the fistulous tract in 1, hypoxemia with termination of the procedure in 1, and failure to advance the stent in 1 patient. TM
drainage was unsuccessful in 1 patient with PSD due to stent
migration following deployment resulting in perforation. The
migrated stent was removed followed by endoscopic closure
of the gastric defect.
There was no difference in the need for endoscopic re-intervention (within 4 weeks from time of TM drainage) between
patients with PDF (5/90; 5.5 %) vs. PSD (6/52; 11.5 %) (OR
2.22; 95 % CI: 0.64 – 7.66; P = 0.33). Endoscopic re-intervention
consisted of stent replacement and/or upsizing. Infection was
the most common indication for re-intervention for PDF (2/90;
2.2 %) and PSD (4/52; 7.7 %) (OR 0.27; 95 % CI: 0.05 – 1.5; P =
0.19). Persistent or enlarging symptomatic pseudocyst was an
indication for re-intervention in 1 patient with PDF and in 2 patients with PSD (OR 0.28; 95 % CI: 0.02 – 3.18; P = 0.55). Endoscopic re-intervention was performed for stent migration in 2
patients with PDF but none with PSD (P = 0.53). There were no
cases of stent occlusion requiring revision in either group.

Procedural adverse events
Overall, AE rates were not significantly different between patients with PDF (12.2 %) vs. PSD (19.2 %) (P = 0.33). Procedural
AEs for pseudocyst drainage are summarized in ▶ Table 3.
Bleeding was managed with endoscopic hemostasis and blood
transfusion (n = 4) or coil embolization by interventional radiology (n = 4). Three cases of perforation during TM stent place-
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▶ Table 1 Patient characteristics of patients with pseudocysts undergoing endoscopic drainage.
Baseline characteristics

PDF (n = 90)

PSD (n = 52)

P value

Age, mean (SD), years

53 (16.1)

51.9 (16.8)

0.54

Males; n(%)

61 (67.8)

32 (61.5)

0.47

Etiology of acute pancreatitis, n(%)
ETOH
Gallstones
Idiopathic
Other

27 (30)
21 (23.3)
23 (25.6)
19 (21.1)

17 (32.7)
16 (30.8)
10 (19.2)
9 (17.3)

0.85
0.43
0.42
0.67

Presence of underlying chronic pancreatitis, n (%)

22 (24.4)

13 (25)

1.00

9 (7.4 – 12.2)

Size of drained pseudocyst, median (interquartile range), cm

9 (7.5 – 13.3)

0.92

Pseudocyst location; n(%)
Head
Body
Tail

22 (24.4)
52 (57.8)
30 (33.3)

13 (25)
35 (67.3)
20 (38.5)

1.00
0.29
0.59

Indication for drainage, n(%)
Pain
Gastric outlet obstruction
Biliary obstruction
Infection

81 (90)
19 (21.1)
4 (4.4)
8 (8.9)

48 (92.3)
7 (13.5)
1 (1.9)
6 (11.5)

0.77
0.37
0.65
0.77

▶ Table 2 Transmural drainage technique.
Transmural drainage technique

PDF (n = 90)

PSD (n = 52)

OR (95 % CI)

P value

Access route; n(%)
Trans-gastric
Trans-duodenal
Unspecified

79 (87.8)
5 (5.6)
6 (6.7)

45 (86.5)
5 (9.6)
2 (3.8)

1.12 (0.40 – 3.09)
0.55 (0.15 – 2.01)
1.79 (0.35 – 9.19)

1.00
0.50
0.71

Type of transmural stent placed, n(%)
Plastic
Metal
Lumen-apposing transmural stent
Unspecified

72 (80)
10 (11.1)
2 (2.2)
6 (6.7)

37 (71.2)
12 (23.1)
3 (5.8)
0

1.62 (0.73 – 3.58)
0.42 (0.17 – 1.05)
0.37 (0.06 – 2.30)
–

0.30
0.09
0.36
0.08

5 (5.5)

6 (11.5)

0.45 (0.13 – 1.56)

0.33

Endoscopic re-intervention within 4 weeks

▶ Table 3 Adverse events.
Adverse event

PDF (n = 90)

PSD (n = 52)

OR (95 % CI)

P value

Bleeding

4 (4.4)

4 (7.7)

0.79 (0.43 – 7.49)

0.46

Perforation

2 (2.2)

2 (3.8)

1.76 (0.24 – 12.88)

0.62

Infection

2 (2.2)

4 (7.7)

0.27 (0.05 – 1.5)

0.19

Cardiopulmonary

1 (1.1)

0

–

1.00

Death

1 (1.1)

0

–

1.00

Other

1 (1.1)

0

–

1.00

0.58 (0.23 – 1.49)

0.33

Overall

11/90 (12.2)

10/52 (19.2)

ment did not require any specific intervention whereas endoscopic removal of a migrated stent and gastric defect closure
was performed in one patient with PSD. Infection was reported
in 6 patients (2 with PDF and 4 with PSD; P = 0.19). All of these
patients were managed with antibiotic therapy and repeat

endoscopic drainage with upsizing of TM stent(s). In addition
to antibiotics and stent upsizing, 4 of these 6 patients also had
additional interventions: 2 patients (1 with PDF and 1 with PSD)
had concomitant insertion of a nasocystic drain and 2 patients
(both with PSD) underwent computed tomography-guided

Yang Dennis et al. Clinical outcomes of … Endoscopy International Open 2017; 05: EE130–EE136

E133

Original article

percutaneous drain placement. These adjunct interventions
were performed given concern that the infected pseudocyst
would not be adequately drained by TM stent upsizing alone.
One patient with PDF died from cardiopulmonary arrest following aspiration.

EUS-guided TM technical success:
PDF 87/90 (97 %) vs. PSD 51/52 (98 %) (P = 1.00)

PDF (n = 90)

PSD (n = 52)

Treatment outcomes and follow-up
The median short-term follow-up was the same for patients
with PDF (50 days; IQR: 35 – 86 days) vs. PSD (50 days; IQR:
37 – 75 days) (P = 0.87). Complete symptomatic resolution at
short-term follow-up was reported in 39 (70.9 %) patients with
PDF and 25 (58.1 %) patients with PSD (Odds ratio [OR] = 1.56;
95 % CI: 0.66 – 3.67; P = 0.38) (▶ Fig. 2). Radiologic resolution
of PFC was significantly higher in PDF group (45 /68; 66.2 %)
compared to the PSD group (21/41; 51.2 %) (OR = 0.30; 95 %
CI: 0.13 – 0.72; P = 0.009) ( ▶ Fig. 2). There was no difference in
symptomatic or radiologic resolution rates in neither group
(PDF or PSD) between patients who had TM drainage with metal versus plastic stents (data not shown).
The median long-term follow-up was 297 (IQR: 59 – 424)
days for patients with PDF and 326 (IQR: 180 – 448) days for
PSD (P = 0.88). At long-term follow-up, there was no significant
difference in symptomatic resolution (70.4 % in PDF vs 66.7 % in
PSD) (OR = 0.84; 95 % CI: 0.22 – 3.26; P = 1.00) or radiologic resolution of pseudocyst (68.9 % in PDF vs 78.6 % in PSD) (OR =
1.65; 95 % CI: 0.37 – 7.39; P = 0.72) between the 3 cohorts
(▶ Fig. 2). In aggregate, 33 (23.2 %) and 98 (69 %) patients
were lost to short- and long-term follow-up, respectively.

Discussion
Endoscopic TM drainage has largely replaced surgery as firstline therapy for management of pancreatic pseudocysts due
its comparable clinical efficacy, shorter post-procedural recovery time, lower costs, and AE rates [6]. While EUS-guided drainage has been recognized as the standard of care for management of symptomatic PFCs [12, 13], the optimal endoscopic approach for each type of PFC has not been well defined, particularly in patients with pseudocysts who are subsequently noted
to have varying degrees of non-liquid component at the time of
the endoscopic procedure (but not seen at time of CECT). In
this large multicenter study, there was no difference in longterm treatment outcomes, need for endoscopic re-intervention, or AE rates in patients with debris-free pseudocysts (PDF)
versus those with pseudocysts containing solid-debris (PSD)
undergoing EUS-guided drainage via transmural stents only.
The Revised Atlanta classification [1] distinguishes types of
PFCs based on features on cross-sectional imaging, including
whether there is an encapsulating wall and the presence of solid components within the collection. While most pseudocysts
are characterized by a well-defined inflammatory capsule with
minimal or no solid material, it is not uncommon in clinical
practice to identify varying amounts of layering internal debris
within the pseudocyst at the time of endoscopic drainage. In
cases where viscous fluid and/or layering debris within a pseudocyst may potentially hinder endoscopic drainage, the use of a
nasocystic drain in addition to endoprosthesis has been pre-
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Median short-term follow-up
50 (35 – 86) days
50 (37 – 75) days

Symptomatic
resolution
39/55 (71 %)

Radiologic*
resolution
45/68 (66 %)

Symptomatic
resolution
25/41 (58 %)

Radiologic*
resolution
21/41 (51 %)

Median long-term follow-up
297 (59 – 424) days
326 (180 – 448) days

Symptomatic
resolution
19/27 (70 %)

Radiologic
resolution
20/29 (69 %)

Symptomatic
resolution
10/15 (67 %)

Radiologic
resolution
11/14 (79 %)

▶ Fig. 2 Treatment outcomes (symptomatic and radiologic resolution) and follow-up.

viously proposed. In a prospective study of 40 patients, Puri et
al demonstrated that pancreatic pseudocyst drainage with
both endoprosthesis and nasocystic tube placement was safe
and associated with high success rate (32/40; 80 %) [14]. More
recently, Siddiqui et al compared outcomes of EUS-guided therapy of PSD by using combined endoprosthesis and a nasocystic
drain (n = 63) versus transmural stents only (n = 24) [15]. Overall, technical success was achieved in 87/88 (99 %) and procedure-related AEs occurred in 9/87 (10.3 %) of the patients. At
1-month follow-up, relief of symptoms and at least 30 % decrease in pseudocyst size was achieved in 85 % of PSD drained
via the combined approach versus 63 % of those treated via
stents alone (OR 3.6; 95 % CI: 1.2 – 10.7; P = 0.03). At a median
follow-up of 16 months (range 13 – 27 months), there was not a
significant difference in treatment success rate between patients who had combined drainage (79 %) versus stent alone
(58 %) (P = 0.06). Overall, the authors concluded that shortterm clinical outcomes in patients with PSD are improved by
combined nasocystic drain and endoprosthesis drainage.
There are several potential limitations of adopting a routine
combined endoprosthesis and nasocystic drain approach for
the management of PSD as suggested by Siddiqui and colleagues. First, all patients in their study were admitted to the hospital after the procedure and pseudocyst lavage via the nasocystic tube was performed with normal saline solution with
100 ml/hour for 48 to 72 hours. Besides the clear risks associated with potential nosocomial exposure during routine postprocedural hospital admission, this clinical practice can significantly increase costs and length of stay associated with the procedure; and thereby, potentially obviates some of the established advantages of endoscopic drainage over a surgical approach. Aggressive irrigation of the cystic cavity requires close
monitoring and ancillary staff resources to minimize the risk of
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serious adverse events such as aspiration. Last but not least,
many patients may not tolerate an indwelling nasocystic tube
for such an extended period of time. As such, it is difficult to
advocate for routine use of combined endoprosthesis and nasocystic drain placement in all patients with PSD, especially in the
absence of conclusive literature supporting its use in this setting.
In this multicenter study, we demonstrate similar long-term
outcomes in patients with PDF versus PSD undergoing EUSguided endoscopic drainage via transmural stents only. Our
technical success rate of TM drainage was high and not significantly different for PDF (96.7 %) versus PSD (98.1 %) (P = 0.63).
This high technical success rate is comparable and in agreement to those previously reported, alluding to the external validity of our findings [6 – 8, 13]. Similar to the prior study by Siddiqui et al, our results suggest higher rate of complete radiologic resolution at short-term follow-up in patients with PDF
(66.2 %) compared to PSD (51.2 %) (OR 0.30; 95 % CI: 0.13 –
0.72; P = 0.009). This would intuitively make sense as a cyst cavity containing layering debris would require more time for its
components to completely liquefy and drain when compared
to a pseudocyst without any debris. In spite of this radiographic
difference, short-term symptomatic resolution rates were
similar between both groups and there was also no difference
in the need for endoscopic re-intervention (5.5 % in PDF vs.
11.5 % in PSD; P = 0.33) at follow-up. Overall, these findings suggest that while short-term radiologic resolution of pseudocyst
may be slower for those with PSD vs. PDF, there was no difference in other surrogate markers (i. e. symptomatic resolution
and need for re-intervention) of clinical improvement between
the 2 groups. Even more importantly, the results from this
study did not demonstrate any statistically significant differences in long-term clinical outcomes or rate of AEs in patients
with PDF or PSD undergoing EUS-guided TM drainage.
This study has several strengths. This is the largest and only
multicenter experience comparing outcomes in patients with
PDF versus PSD undergoing EUS-guided drainage with transmural stents only. Second, all patients with pseudocysts were
identified based on established criteria and by the omission of
patients with evidence of necrotizing pancreatitis or obvious
WON on index cross-sectional imaging in an effort to avoid
PFC misclassification [1, 16]. Third, instead of using post-drainage PFC size as the only surrogate marker for treatment success, the main outcomes in this study were defined as complete
resolution of symptoms and radiographic findings on follow-up
and the need for endoscopic re-intervention, presumably clinically more relevant endpoints. Lastly, not only was treatment
efficacy assessed immediately following endoscopic drainage,
but long-term treatment effect was estimated by evaluating
clinical outcomes after transmural stent removal. This is a key
point as ultimate therapeutic outcomes should be assessed
once the prostheses are removed, thus signaling the true completion of therapy. T
There are also limitations to this study. The study design was
retrospective with its inherent limitations. As such, presence of
solid debris within a pseudocyst was qualitatively determined
by the endoscopist at the time of the EUS but a standardized

quantitative assessment was not available across all participating institutions. This potentially increases the heterogeneity
within the PSD group and underscores the need for future prospective comparative trials. Second, in aggregate, rates of
symptom and radiologic resolution (68.9 % – 78.6 %) of pseudocysts following endoscopic drainage in this study appear to be
lower than those reported in the literature, which range from
75 % to 100 % [6 – 8, 13, 14]. This discrepancy in outcomes can
be in part accounted for by the heterogeneous criteria used in
defining treatment success, varied procedural techniques employed, diverse patient populations and timing of the interventions among the prior studies, as well as our own use of very
stringent criteria for ST and LT follow-up and definitions of success. Another major limitation is that a significant portion of
patients were lost to follow-up and thus the potential for selection bias. Most of the participating institutions in this study are
tertiary referral centers and thus a large proportion of patients
included in this study were lost to follow-up upon completion
of the intervention. We acknowledge that the loss to LT followup limits the interpretability of our current findings and conclusions. Consequently, due to the relative small sample size, the
study could have been underpowered to detect statistically significant differences between the 2 groups. Lastly, while this
study represents the largest multicenter series evaluating outcomes associated with EUS-guided drainage of PSD, small sample size on subgroup analysis could have precluded detection of
any meaningful differences in outcomes. Hence, the lack of statistically significant difference may not necessarily exclude the
possibility of clinically relevant differences.

Conclusion
In summary, this study demonstrated similar treatment outcomes in patients with PDF versus PSD undergoing EUS-guided
drainage via placement of transmural stents only. Drainage was
successful in most of the patients with placement of transmural
plastic stents, which suggests that this may still be an efficacious and cost-effective alternative to use of fully-covered lumen-apposing stents. While short-term radiologic resolution
of pseudocyst was higher in PDF versus PSD, there were no differences in need for endoscopic re-intervention or long-term
symptomatic or radiologic outcomes between the 2 groups. Future larger comparative prospective studies are needed to evaluate whether transmural stenting alone and the type of stent
for that matter, is sufficient for adequate drainage of patients
with PSD.
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